DK167532B1 - 2-(1-pyridylalkanoyloxymethylen)tetrahydrofuran- og -tetrahydrothiophensalte, fremgangsmaade til fremstilling deraf og laegemidler indeholdende saadanne salte - Google Patents

2-(1-pyridylalkanoyloxymethylen)tetrahydrofuran- og -tetrahydrothiophensalte, fremgangsmaade til fremstilling deraf og laegemidler indeholdende saadanne salte Download PDF

Info

Publication number
DK167532B1
DK167532B1 DK291088A DK291088A DK167532B1 DK 167532 B1 DK167532 B1 DK 167532B1 DK 291088 A DK291088 A DK 291088A DK 291088 A DK291088 A DK 291088A DK 167532 B1 DK167532 B1 DK 167532B1
Authority
DK
Denmark
Prior art keywords
salts
compound
tetrahydrothiophenal
pyridylalkanoyloxymythylene
tetrahydrofurane
Prior art date
Application number
DK291088A
Other languages
Danish (da)
English (en)
Other versions
DK291088D0 (da
DK291088A (da
Inventor
Jean-Jacques Godfroid
Pierre Braquet
Francoise Heymans
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of DK291088D0 publication Critical patent/DK291088D0/da
Publication of DK291088A publication Critical patent/DK291088A/da
Application granted granted Critical
Publication of DK167532B1 publication Critical patent/DK167532B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK291088A 1987-05-29 1988-05-27 2-(1-pyridylalkanoyloxymethylen)tetrahydrofuran- og -tetrahydrothiophensalte, fremgangsmaade til fremstilling deraf og laegemidler indeholdende saadanne salte DK167532B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878712693A GB8712693D0 (en) 1987-05-29 1987-05-29 Tetrahydrofurans etc
GB8712693 1987-05-29

Publications (3)

Publication Number Publication Date
DK291088D0 DK291088D0 (da) 1988-05-27
DK291088A DK291088A (da) 1988-11-30
DK167532B1 true DK167532B1 (da) 1993-11-15

Family

ID=10618139

Family Applications (1)

Application Number Title Priority Date Filing Date
DK291088A DK167532B1 (da) 1987-05-29 1988-05-27 2-(1-pyridylalkanoyloxymethylen)tetrahydrofuran- og -tetrahydrothiophensalte, fremgangsmaade til fremstilling deraf og laegemidler indeholdende saadanne salte

Country Status (32)

Country Link
US (1) US5017588A (ko)
JP (1) JPH0631228B2 (ko)
KR (1) KR960005152B1 (ko)
AR (1) AR243885A1 (ko)
AT (1) AT395715B (ko)
AU (1) AU610789B2 (ko)
BE (1) BE1002146A3 (ko)
CA (1) CA1317959C (ko)
CH (1) CH674985A5 (ko)
DE (1) DE3818106A1 (ko)
DK (1) DK167532B1 (ko)
ES (1) ES2009924A6 (ko)
FI (1) FI89353C (ko)
FR (2) FR2615735B1 (ko)
GB (2) GB8712693D0 (ko)
GR (1) GR1000147B (ko)
HK (1) HK101790A (ko)
IE (1) IE61341B1 (ko)
IN (1) IN168799B (ko)
IT (1) IT1219698B (ko)
LU (1) LU87229A1 (ko)
MA (1) MA21289A1 (ko)
MY (1) MY103289A (ko)
NL (1) NL192203C (ko)
NO (1) NO170086C (ko)
NZ (1) NZ224775A (ko)
OA (1) OA08878A (ko)
PT (1) PT87585B (ko)
SE (1) SE466449B (ko)
SG (1) SG93790G (ko)
TN (1) TNSN88049A1 (ko)
ZA (1) ZA883731B (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8701727D0 (en) * 1987-01-27 1987-03-04 Scras Tetrahydrofuran derivatives
GB8712694D0 (en) * 1987-05-29 1987-07-01 Scras Tetrahydrofurans etc
ES2010568A6 (es) * 1988-08-04 1989-11-16 Uriach & Cia Sa J Procedimiento para la obtencion de derivados 2,5-disustituidos de tetrahidrofurano.
ES2013834A6 (es) * 1989-01-30 1990-06-01 Uriach & Cia Sa J Procedimiento para la obtencion de derivados 4-sustituidos de 2-alcoxitetrahidrofurano.
US5118708A (en) * 1989-06-23 1992-06-02 Norwich Eaton Pharmaceuticals, Inc. Use of 5-phenyl-2-furan esters, amides and ketones as neuroprotective agents
US20110097352A9 (en) * 1992-01-29 2011-04-28 Pharmexa Inc. Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
KR100326276B1 (ko) * 1999-12-14 2002-03-08 정명식 테트라하이드로푸란 유도체, 이의 제조방법 및 이를포함하는 항진균제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1088880A (en) * 1964-11-18 1967-10-25 Vantorex Ltd ª‡-cycloalkyleneimino-substituted esters
GB8701727D0 (en) * 1987-01-27 1987-03-04 Scras Tetrahydrofuran derivatives
GB8712694D0 (en) * 1987-05-29 1987-07-01 Scras Tetrahydrofurans etc

Also Published As

Publication number Publication date
TNSN88049A1 (fr) 1990-07-10
MY103289A (en) 1993-05-29
JPH0631228B2 (ja) 1994-04-27
NO170086B (no) 1992-06-01
FR2615735B1 (fr) 1991-01-11
GB2205100B (en) 1990-08-15
GB8812488D0 (en) 1988-06-29
DK291088D0 (da) 1988-05-27
NO882335L (no) 1988-11-30
GB2205100A (en) 1988-11-30
NL192203C (nl) 1997-03-04
IT8820773A0 (it) 1988-05-27
PT87585B (pt) 1992-09-30
SE8801964L (sv) 1988-11-30
NO170086C (no) 1992-09-09
NL192203B (nl) 1996-11-01
IE881599L (en) 1988-11-29
HK101790A (en) 1990-12-14
IN168799B (ko) 1991-06-08
JPS649988A (en) 1989-01-13
NO882335D0 (no) 1988-05-27
DK291088A (da) 1988-11-30
NL8801315A (nl) 1988-12-16
GR1000147B (el) 1991-09-27
GR880100342A (en) 1989-02-23
ZA883731B (en) 1989-02-22
CH674985A5 (ko) 1990-08-15
LU87229A1 (fr) 1988-12-13
PT87585A (pt) 1989-05-31
US5017588A (en) 1991-05-21
KR880013928A (ko) 1988-12-22
NZ224775A (en) 1990-01-29
DE3818106A1 (de) 1988-12-15
OA08878A (fr) 1989-10-31
FI89353B (fi) 1993-06-15
BE1002146A3 (fr) 1990-07-31
SE466449B (sv) 1992-02-17
FR2615854A1 (fr) 1988-12-02
CA1317959C (en) 1993-05-18
AU1672288A (en) 1988-12-01
ES2009924A6 (es) 1989-10-16
FI89353C (fi) 1993-09-27
GB8712693D0 (en) 1987-07-01
IT1219698B (it) 1990-05-24
ATA140788A (de) 1992-07-15
FI882475A (fi) 1988-11-30
IE61341B1 (en) 1994-11-02
FR2615735A1 (fr) 1988-12-02
FI882475A0 (fi) 1988-05-26
MA21289A1 (fr) 1988-12-31
AT395715B (de) 1993-02-25
KR960005152B1 (ko) 1996-04-22
SE8801964D0 (sv) 1988-05-26
AU610789B2 (en) 1991-05-23
SG93790G (en) 1991-01-18
FR2615854B1 (fr) 1990-12-28
AR243885A1 (es) 1993-09-30
DE3818106C2 (ko) 1993-07-01

Similar Documents

Publication Publication Date Title
EP3555064B1 (en) Glp-1 receptor agonists and uses thereof
US4737518A (en) Lipid derivatives, their production and use
EP3728222B1 (en) Cyclohexyl acid pyrazole azines as lpa antagonists
AU2018392324A1 (en) Cyclohexyl acid triazole azines as LPA antagonists
DK167532B1 (da) 2-(1-pyridylalkanoyloxymethylen)tetrahydrofuran- og -tetrahydrothiophensalte, fremgangsmaade til fremstilling deraf og laegemidler indeholdende saadanne salte
AU7446400A (en) Quinuclidine compounds and drugs containing the same as the active ingredient
US11866446B2 (en) Inhibitors of APOL1 and methods of using same
EP0301751B1 (en) Pyridinium derivatives, their production and use
WO2008109991A1 (en) Inhibitors of carnitine palmitoyltransferase and treating cancer
CA2075673A1 (en) (2-alkyl-3-pyridyl)methylpiperazine derivatives
KR101911324B1 (ko) 신규한 치환 이소퀴놀린 유도체
DK167678B1 (da) 2-tridecyl-5-(kvaternaert ammoniumalkoxymethyl)tetrahydrofuran- og -tetrahydrothiophenforbindelser, fremgangsmaade til fremstilling deraf og laegemidler indeholdende saadanne forbindelser
US5134151A (en) 2-picolylamine derivatives
Newkome et al. Chemistry of heterocyclic compounds. 28. Reactions of halopyridines with mercaptide. Synthesis of multiheteromacrocycles possessing 2, 6-pyridino subunits connected by carbon-sulfur linkages
CN115066428A (zh) 硼酸衍生物
US5103007A (en) Lipids
EP0255366A2 (en) Nitrogen- and sulfur-containing lipid compound, their production and use
US4946955A (en) Method for the preparation of polycyclic 1,3-thiazolidines
OA20663A (en) 2-formyl-3-hydroxyphenyloxymethyl compounds capable of modulating hemoglobin.
JPH0314556A (ja) 脂質
JPH03218343A (ja) カルボキシイミダミド誘導体
EA040816B1 (ru) Агонисты рецептора glp-1 и их применение
JPH0256451A (ja) グリセリン誘導体

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed